2022
DOI: 10.1007/s11010-022-04371-x
|View full text |Cite
|
Sign up to set email alerts
|

Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 26 publications
0
3
0
Order By: Relevance
“…S6B–F ). On the contrary, miR-653-5p exhibited a universally suppressive effect on the progression of various cancers [ 33 , 34 ]. Moreover, we detected that there existed a negative correlation between the expression of circTBPL1 and miR-653-5p in breast cancer cells (Supplementary Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…S6B–F ). On the contrary, miR-653-5p exhibited a universally suppressive effect on the progression of various cancers [ 33 , 34 ]. Moreover, we detected that there existed a negative correlation between the expression of circTBPL1 and miR-653-5p in breast cancer cells (Supplementary Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Although no statistical significance was found in the correlation analysis, the expression of miR-653-5p was negatively related with circTBPL1 in breast cancer cells, which might attribute to the limited number of cells. Interestingly, miR-653-5p was identified as a general sponging target for various non-coding RNAs, exerting a tumor-suppressing effect in many cancer types, such as prostate cancer [ 33 ], ovarian cancer [ 34 ], and melanoma [ 52 ]. Consist with the previous reports, miR-653-5p overexpression could significantly inhibit cell viability and motility, confirming the tumor-repressive role of miR-653-5p in breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…For instance, a recent study shows that exosomal miR-653-5p derived from mesenchymal stem cells suppresses laryngeal papilloma progression [ 21 ]. In addition, miR-653-5p plays a role in cell proliferation in various cancer cells, such as ovarian cancer [ 22 ], papillary thyroid carcinoma [ 23 ], breast cancer [ 24 , 25 , 26 ], gastric cancer [ 27 ], and lung cancer [ 28 , 29 ]. Although miR-374c-5p is less well characterized, recent studies show that miR-374c-5p secreted from mesenchymal stem cells inhibits cancer growth and metastasis formation by regulating the epithelial–mesenchymal transition [ 30 , 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Hsa‐miR‐216a, hsa‐miR‐3684, hsa‐miR‐4437, hsa‐miR‐641, and hsa‐miR‐552 have been reported to play suppressive or promotive roles in cancer. Hsa‐miR‐653 has been revealed to inhibit cancer progression in hepatocellular carcinoma, prostate cancer, breast cancer, papillary thyroid carcinoma, ovarian cancer, and gastric cancer, 59 , 60 , 61 , 62 , 63 , 64 while Liu et al reported that miR‐653 enhances CRC progression by targeting circSETD3/KLF6 axis recently. 65 Why does miR‐653 play an opposite role in CRC?…”
Section: Discussionmentioning
confidence: 99%